Journal
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
Volume 76, Issue 4, Pages 762-766Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1271/bbb.110879
Keywords
aggregation; Alzheimer's disease; amyloid beta; coumarin; globulomer
Categories
Funding
- [22651079]
- Grants-in-Aid for Scientific Research [22651079] Funding Source: KAKEN
Ask authors/readers for more resources
Aggregations of proteins are in many cases associated with neurodegenerative diseases such as Alzheimer's (AD). Small compounds capable of inhibiting protein aggregation are expected to be useful for not only in the treatment of disease but also in probing the structures of aggregated proteins. In previous studies using phage display, we found that arginine-rich short peptides consisting of four or seven amino acids bound to soluble 42-residue amyloid beta (A beta 42) and inhibited globulomer (37/48 kDa oligomer) formation. In the present study, we searched for arginine-containing small molecules using the SciFinder searching service and tested their inhibitory activities against A beta 42 aggregation, by sodium dodecyl sulfate (SDS)-PAGE and thioflavine T binding assay. Commercially available Arg-Arg-7-amino-4-trifluoromethylcoumarin was found to exhibit remarkable inhibitory activities to the formation of the globulomer and the fibril of A beta 42. This chimera-type tri-peptide is expected to serve as the seed molecule of a potent inhibitor of the A beta aggregation process.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available